> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Panel to Discuss Valeant BLA for Plaque Psoriasis
- URL: https://www.fdaweb.com/panel-to-discuss-valeant-bla-for-plaque-psoriasis/
- Published: 2016-06-10T12:00:00.000Z
- Updated: 2026-09-14T21:09:02.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135907

*Federal Register* Notice: FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will meet 7/19, from 8 a.m. to 5 p.m. at FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31, Conference Center, the Great Room (Rm. 1503), Silver Spring, MD. The committee will discuss a Valeant Pharmaceuticals Luxemborg BLA for brodalumab injection, a human monoclonal antibody for the proposed use for treating moderate to severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Contact **Jennifer Shepherd**, (301) 796-9001\. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-06-10/pdf/2016-13710.pdf?ref=fdaweb.com)